Abstract Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about how various substances are used with one another. In the present study 149 drug‐using university students completed structured interviews about their use of various substances. For each substance ever used, participants provided details about the type, order and amount of all substances...
Published case reports on complex visual hallucinations (CVH) occurring during antidepressant (AD) treatment were reviewed. Thirteen cases of CVH associated with SSRI treatment, 16 cases during tricyclic drug treatment and seven cases with other AD drug treatments were found. Nine patients were taking concomitant drugs while on therapy with SSRIs and four had a neurological disease in addition...
Abstract Previous research suggests that MDMA users are impaired in various aspects of cognitive functioning, however, it remains unclear whether they might experience deficits in established measures of verbal working memory functioning. In the present study current and previous MDMA users were compared with non‐users on verbal working memory measures including reading and computation span....
Abstract This study examined the reported psychological effects of different patterns of MDMA use in men and women, and how they are modified by use of other psychoactive substances. A semi‐structured interview was conducted with 466 regular MDMA users, exploring the perceived acute, sub‐acute and long‐term subjective effects of this drug. Factor analysis established three main categories of...
Abstract The present study reports on all deaths related to taking ecstasy (alone, or in a polydrug combination) occurring in England and Wales in the time frame August 1996–April 2002. Data presented here are based on all information recorded in the National Programme on Substance Abuse Deaths (np‐SAD) database. The np‐SAD regularly receives all information on drug related deaths in addicts...
Abstract Rationale The recreational use of MDMA/Ecstasy (3,4‐methylenedioxymethamphetamine) is associated with many psychobiological problems, but there is a paucity of data on how these relate to the level of past use. Objectives: to assess the incidence of Ecstasy‐attributed problems as reported by novice, moderate and heavy users. Methods: 763 unpaid volunteers took part in a WWW study of...
Abstract MDMA (3,4‐methylenedioxymethamphetamine) or ‘Ecstasy’ was scheduled as an illegal drug in 1986, but since then its recreational use has increased dramatically. This review covers 15 years of research into patterns of use, its acute psychological and physiological effects, and the long‐term consequences of repeated use. MDMA is an indirect monoaminergic agonist, stimulating the release...
Abstract In preclinical studies, 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) has been shown to release serotonin (5‐HT), dopamine and norepinephrine. However, the role of these neurotransmitters and their corresponding receptor sites in mediating the subjective effects of MDMA has not yet been studied in humans. Therefore, we investigated the effects of three different neuroreceptor...
Abstract 3,4‐methylenedioxymethamphetamine (MDMA or Ecstasy) has been implicated in the onset of a number of psychological disorders and associated with a number of psychiatric symptoms that have persisted after cessation of the drug. This paper is a review of the published psychiatric case studies from the last 10 years involving MDMA. Only 24% of patients had a previous psychiatric history...
Abstract The popular recreational drug Ecstasy (3,4‐methylenedioxymethamphetamine, or MDMA, and related congeners) is neurotoxic upon central serotonergic systems in animal studies. So far, the most convincing evidence for neurotoxicity‐related functional deficits in humans derives from neurocognitive studies demonstrating dose‐related memory problems in Ecstasy users. The aim of the current...
Abstract Human users of 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) users may be at risk of developing MDMA‐induced neuronal injury. Previously, no methods were available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivo neuroimaging tools has begun to provide insights into the effects of MDMA in the human brain. In this...
Abstract Chronic use of MDMA (3,4‐methylenedioxymethamphetamine), or ‘ecstasy’, is associated with significant cognitive impairments, particularly in laboratory and field tests of memory for previously encoded material. Less is known about the effects of a history of MDMA use on aspects of everyday cognitive functioning–of which prospective memory (typically characterised as ‘remembering to do...
This study investigated possible interactions between alcohol and hallucinogens in 22 lysergic acid diethylamide (LSD) and/or psilocybin users through retrospective structured interviews. Of those who had used LSD with alcohol, 86;7 per cent reported a complete blockade of subjective alcohol effects, while the remaining cases reported a diminished response. In addition, 60 per cent of...
Twenty-one recreational polydrug users (age range: 17–34 years), were recruited into the study using the 'snowball' technique (Solowij et al., 1992). All had used MDMA (3,4-methylenedioxymethamphetamine, or 'Ecstasy'), LSD (lysergic acid diethylamide), and amphetamine, on different occasions. They completed modified Profile of Mood States Questionnaires, to indicate their typical feeling states...
Twenty recreational drug users were asked to describe the psychological and physiological effects they experienced under MDMA (3,4-methylenedioxymethamphetamine). The subjects comprised 11 males and nine females, in the age range 18–31 years. Five subjects had taken MDMA once, nine had taken it 2–9 times, while six subjects had taken it +10 times. Each subject completed a modified Profile of...
Abstract The aim of this study was to examine the effect of acute administration of (±)3,4‐methylenedioxymethamphetamine (MDMA) (20 mg/kg, i.p.) on colonic temperature, serum corticosterone and brain biogenic amine concentrations in group‐housed male and female rats and to determine if there are any gender differences in susceptibility to MDMA‐induced changes. Prior to treatment, basal colonic...
Abstract Despite its early promise as ‘the chemical key to schizophrenia’, and its manifest properties as a psychotomimetic, LSD failed to catch on as a drug model for human psychosis. The reasons for this and the longstanding preference, instead, for the amphetamine model are examined. It is argued that the rejection of LSD was not just a scientific decision, but was influenced by increasing...
AbstractNitrous oxide, commonly used in medical settings for its anxiolytic, analgesic, and anesthetic effects, is also used recreationally. One method of using this agent recreationally is to inhale a pure bolus of nitrous oxide (N2 O) one or more times in succession. The effects of such an inhalation mode (i.e. brief inhalation of higher concentrations of N2 O) have not been adequately...
AbstractSubjects (16 men and 16 women) breathing 30 per cent nitrous oxide in oxygen, or 100 per cent oxygen, were tested to see if the effects of nitrous oxide on memory varied with different types of auditory stimuli and memory‐testing procedures. The drug produced substantial memory impairments. These impairments were milder in forced‐choice recognition than in yes/no recognition and for...